Alpha Cognition (ACOG) Return on Sales (2025)

Alpha Cognition's (ACOG) quarterly Return on Sales came in at 0.03% in Q4 2025, down 717.19% quarter-over-quarter from 0.0% in Q3 2025.

Alpha Cognition (ACOG) Return on Sales (2025) Analysis & Trends

Alpha Cognition's Return on Sales history runs 1 years deep, the most recent figure standing at 0.03% for Q4 2025.

On a quarterly basis, Return on Sales changed N/A year-over-year to 0.03% in Q4 2025; TTM through Dec 2025 was 0.02%, a N/A change from a year earlier, with the FY2025 full-year figure at 0.04%, changed N/A from the prior year.
Return on Sales eased to 0.03% in Q4 2025 per ACOG's latest filing, from 0.0% in the prior quarter.
Across five years, Return on Sales topped out at 0.0% in Q3 2025 and bottomed at 0.08% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.00%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	0.00%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.00%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	0.00%
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Alpha Cognition	145.51 Mn	79.41 Mn	2.61 Mn	-0.03%

Download Data